Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients.

Alessio GerussiCristina RigamontiChiara EliaNora CazzagonAnnarosa FloreaniRoberta PozziPietro PozzoniErnesto ClaarLuisa PasuloStefano FagiuoliLaura CristoferiMarco CarboneInvernizzi Pietro

Published in: Hepatology communications (2020)

Patients under immunosuppressive therapy for AIH developing COVID-19 show a disease course presumptively similar to that reported in non-immunosuppressed population. These data might help medical decision when dealing with SARS-CoV-2 infection in immunocompromised patients.

Keyphrases

coronavirus disease
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
healthcare
intensive care unit
electronic health record
deep learning
big data
respiratory failure